Satellite Glial Cell Activation and Sympathetic Imbalance in Cardiomyopathy and Arrhythmias
Satellite Glial Cell Activation and Sympathetic Imbalance in Cardiomyopathy and Arrhythmias
批准号:
10416426
负责人:
Olujimi A Ajijola
金额:
$59.18万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-01 至 2026-03-31
关键词:
AblationAnimalsArrhythmiaAttenuatedCalcium SignalingCardiacCardiomyopathiesCatecholaminesCause of DeathChronicChronic DiseaseCommunicationConnexin 43DataDilated CardiomyopathyDiseaseElectrophysiology (science)FibrosisFunctional disorderFutureG-Protein-Coupled ReceptorsGap JunctionsGlial Fibrillary Acidic ProteinGoalsHealthHeartHeart DiseasesHeart InjuriesHeart failureHumanHyperactivityInflammatoryInflammatory Bowel DiseasesInjuryIschemiaLeft Ventricular DysfunctionLeft Ventricular RemodelingLinkMediatingMedicalModelingMorphologyMusMyocardial InfarctionMyocardiumNervous system structureNeurogliaNeuronal DysfunctionNeuronsNorepinephrinePatientsPharmaceutical PreparationsPlayPreventionProcessPurinesReperfusion InjuryReperfusion TherapyResearch PersonnelRoleSignal TransductionSignaling MoleculeStructure of stellate ganglionSupporting CellSympathetic GangliaSynapsesTechniquesTestingTherapeuticTransgenic MiceUp-RegulationVentricular ArrhythmiaVentricular TachycardiaViralbasebeta-adrenergic receptorcardiogenesiscell typechronic paincytokineglial activationhuman datahuman modelinhibitormortalitymortality riskmouse modelmultidisciplinaryneurochemistryneuronal excitabilityneuroregulationneurotransmissionnovelorgan injuryporcine modelpreventrelating to nervous systemrelease factorside effecttargeted treatmenttherapeutic targettool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Cardiac injury predisposes patients to heart failure (HF), and ventricular tachycardia/fibrillation (VT/VF).
Development of HF and VT/VF after cardiac injury is tightly linked to sympathetic neural remodeling. Although
several medications targeting cardiac sympathetic excess reduce mortality following cardiac injury, significant
shortcomings of these drugs include off-target effects, limited efficacy, and focus on downstream
consequences of neural remodeling such as excess catecholamine release, rather than preventing it upstream.
In this proposal, we build on strong preliminary data from humans, porcine, and murine models demonstrating
that satellite glial cell (SGC) activation is a central feature of chronic cardiac injury. Activated glia release
inflammatory cytokines, ATP, and other factors that modulate neuronal function. Chemogenetic upregulation of
glial calcium signaling (as observed in activated glia) increase cardiac sympathetic neuronal excitability,
synaptic efficacy, and tonic firing. Based on these novel findings, the goal of this proposal is to test the
hypothesis that satellite glial activation and enhanced glial-neuronal signaling is a primary driver of cardiac
sympathetic neuronal dysfunction, heart failure and VT/VF after cardiac injury.
We will test our hypotheses using novel tools from a multidisciplinary team of investigators in 3 specific
aims in two murine models of cardiac injury (ischemia-reperfusion and dilated cardiomyopathy). We will test
whether following cardiac injury, satellite glial cell activation within stellate ganglia exacerbates neuronal and
cardiac remodeling (structural and functional) to promote LV dysfunction and VT/VF (Aim 1). We will
investigate the mechanisms by which cardiac injury activates SGCs in stellate ganglia after injury (Aim 2).
Finally, we will determine whether targeting glial Gq-GPCR Ca2+ signaling or Cx43-mediated glia-neuron/glial-
glial communication mitigates adverse remodeling and arrhythmogenesis following cardiac injury (Aim 3). The
results of this proposal will 1) indicate whether and how satellite glial cell activation contributes to sympathetic
imbalance after cardiac injury; and 2) determine whether targeting satellite glial cell activation offers
therapeutic potential in chronic cardiac injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antiarrhythmic mechanisms of chronic vagal nerve stimulation in sympathetic neurons
-
批准号:10635151
-
项目类别:
-
资助金额:$4.08万
-
财政年份:2023
-
负责人:Olujimi A Ajijola
-
依托单位:
Antiarrhythmic mechanisms of chronic vagal nerve stimulation in sympathetic neurons
-
批准号:10627579
-
项目类别:
-
资助金额:$47.31万
-
财政年份:2023
-
负责人:Olujimi A Ajijola
-
依托单位:
Core A: Ultrastructural Assessment & Human Tissue
-
批准号:10627575
-
项目类别:
-
资助金额:$33.97万
-
财政年份:2023
-
负责人:Olujimi A Ajijola
-
依托单位:
Satellite Glial Cell Activation and Sympathetic Imbalance in Cardiomyopathy and Arrhythmias
-
批准号:10599342
-
项目类别:
-
资助金额:$58.09万
-
财政年份:2022
-
负责人:Olujimi A Ajijola
-
依托单位:
Mechanisms of Cardiac TRPV1 Afferent Remodeling in Ventricular Arrhythmias
-
批准号:10278404
-
项目类别:
-
资助金额:$48.41万
-
财政年份:2021
-
负责人:Olujimi A Ajijola
-
依托单位:
Mechanisms of Cardiac TRPV1 Afferent Remodeling in Ventricular Arrhythmias
-
批准号:10674847
-
项目类别:
-
资助金额:$56.61万
-
财政年份:2021
-
负责人:Olujimi A Ajijola
-
依托单位:
The University of California - Los Angeles (UCLA) Resident Scientist Training Program (RSTP)
-
批准号:10593059
-
项目类别:
-
资助金额:$17.89万
-
财政年份:2020
-
负责人:Olujimi A Ajijola
-
依托单位:
The University of California - Los Angeles (UCLA) Resident Scientist Training Program (RSTP)
-
批准号:10373019
-
项目类别:
-
资助金额:$34.48万
-
财政年份:2020
-
负责人:Olujimi A Ajijola
-
依托单位:
Antiarrhythmic Mechanisms of Bilateral Cardiac Sympathetic Decentralization
-
批准号:9182901
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2014
-
负责人:Olujimi A Ajijola
-
依托单位:
Antiarrhythmic Mechanisms of Bilateral Cardiac Sympathetic Decentralization
-
批准号:8804849
-
项目类别:
-
资助金额:$13.31万
-
财政年份:2014
-
负责人:Olujimi A Ajijola
-
依托单位:
Antiarrhythmic Mechanisms of Bilateral Cardiac Sympathetic Decentralization
-
批准号:8972033
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2014
-
负责人:Olujimi A Ajijola
-
依托单位:
UCLA-Caltech Medical Scientist Training Program
-
批准号:10409739
-
项目类别:
-
资助金额:$148.29万
-
财政年份:1983
-
负责人:Olujimi A Ajijola
-
依托单位:
UCLA-Caltech Medical Scientist Training Program
-
批准号:10632114
-
项目类别:
-
资助金额:$145.49万
-
财政年份:1983
-
负责人:Olujimi A Ajijola
-
依托单位:
海外基金